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Simultaneous determination of enantiomers of structurally related
anticholinergic analogs in human serum by liquid chromatography–
electrospray ionization mass spectrometry with on-line sample
cleanup
ˇ
´ ´Vladimır Capk , Yan X
Introduction synaptic junctions, which consequently leads to
inhibition of transmission of certain nerve impulses.
Trihexyphenidyl (THP), procyclidine and Side effects of THP include bradycardia, distur-
biperiden (Fig. 1) are anticholinergic drugs adminis- bances of recent memory, and myasthenia gravis.
tered as racemates for the treatment of Parkinson’s Among psychotic patients, it demonstrated hal-
disease and extrapyramidal side effects of neurolep- lucinogenic and euphoric properties that led to its
tics [1–4]. Anticholinergic drugs compete with the frequent abuse either alone or in the combination
neurotransmitter acetylcholine for its receptor sites at with other opiates and narcotics [5]. Other side
effects of common anticholinergic drugs include
blurred vision, constipation, dryness of the mouth,
mental disturbances, slurred speech, and urinary
urgency or retention [6]. Understanding the clinical
pharmacology of these drugs is the first step toward
the elimination of these adverse side effects.
It has been long recognized that receptor-binding
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Fig. 1. Chemical structures of trihexyphenidyl, procyclidine, biperiden and diphenidol (I.S.).
sites in biological systems are often asymmetrical preparation with LC–ESI-MS chiral analysis. On-
and therefore capable of discriminating between line sample preparation is accomplished using a
optical isomers of chiral drugs [7]. Consequently, ‘‘semi-permeable surface’’ (SPS) C cartridge col-18
two enantiomers of a racemic drug may have differ- umn for exclusion of serum proteins and retention of
ent pathways of their absorption, distribution, and drug molecules. The elution of drugs to LC–ESI-MS
metabolism in human body. Hence, these enantio- system is accomplished by changing elution strength
mers can have different activity and toxicity in the of the mobile phase. The drug molecules are then
body. It is not unusual in clinical pharmacology that separated on a b-cyclodextrin (b-CD) column into
one enantiomer of a drug is more potent than the their individual enantiomers based on the improve-
other, or one has a therapeutic effect whereas the ment of our recent work [25]. Quantitation is done
other has serious adverse drug reactions [8]. It was by ESI-MS in the selected ion monitoring (SIM)
indicated by previously published studies [7,9–15] mode. The entire analysis can be automated and
that (R)-enantiomers of THP and procyclidine have requires little operator skill. We believe that the
significantly higher affinities for muscarinic receptor method developed provides a useful analytical meth-
subtypes than the corresponding (S)-enantiomers, od for the determination of enantiomers of THP,
and the binding patterns of their (R)- and (S)-en- procyclidine, and biperiden in human serum. It can
antiomers are different. In case of biperiden, it was be used in pharmacological, forensic and toxicologi-
shown that (1)-enantiomer was able to differentiate cal studies where the simultaneous determination of
at least three populations of muscarinic receptor multi-drug mixtures is required.
subtypes whereas (2)-enantiomer was nearly devoid
of such selectivity [16]. However, these studies
showed no conclusions about the potency of the
‘‘high affinity’’ enantiomer because no correlation Experimental
was observed between its potency and the affinity
ratios of the two enantiomers [7,10]. This situation Materials
was in part due to the lack of sensitive stereoselec-
tive analytical methodology for the determination of DL-Trihexyphenidyl hydrochloride, DL-procyc-
these enantiomers in biological fluids. lidine hydrochloride, diphenidol hydrochloride, am-
In this work, we present an analytical method for monium acetate (.98%), acetonitrilie (HPLC grade)
the simultaneous determination of enantiomers of and methanol (HPLC grade) were from Sigma (St.
THP, procyclidine and biperiden in human serum by Louis, MO, USA). Glacial acetic acid (HPLC grade)
liquid chromatography–electrospray ionization mass was from J.T. Baker (Phillipsburgh, NJ, USA).
spectrometry (LC–ESI-MS) with on-line sample Triethylamine (TEA, .99%) was from Aldrich
extraction. The method employs a column-switching (Milwaukee, WI, USA). DL-Biperiden hydrochloride
technique [17–24] to streamline the on-line sample was donated by Knoll Pharmaceutical (Mount Olive,
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NJ, USA). Control human serum (catalog No. through Whatman nylon syringe filters (sterile, 4
2930149) was from ICN (Costa Mesa, CA, USA). mm, 0.2-mm pore) from Fisher (Itasca, IL, USA). All
Deionized water was obtained from a NANOpure serum and aqueous solutions were filtered through
water system (Branstead /Thermolyne, Dubuque, IA, Corning cellulose acetate syringe filters (sterile, 47
USA). Standard aqueous solutions of procyclidine, mm, 0.45 mm pore) from Fisher as well.
THP, biperiden, and diphenidol were prepared by
dissolving appropriate amounts of solid compounds Instrumentation
in deionized water and serially diluting the resulting
solutions with deionized water. Standard solutions The column-switching setup used for this work is
for chiral separation optimization were prepared by schematically shown in Fig. 2. It included two HPLC
dissolving appropriate amounts of solid compounds systems (one for on-line sample extraction, and the
in the analytical column mobile phase and appro- other for chiral separation and detection). These
priate dilutions of the resulting solutions with the systems were connected via a Rheodyne 7000 two-
analytical column mobile phase. position six-port switching valve (Supelco, Belle-
In this work, the analytical column mobile phase fonte, PA, USA). The on-line sample extraction
was filtered through a Fluoropore PTFE membrane system consisted of a GP 40 gradient LC pump
(type FH, 0.5-mm pore) filter (Millipore, Bedford, (Dionex, Sunnyvale, CA, USA), a HP 1100 auto-
MA, USA) prior to use. Standard solutions prepared sampler (Hewlett-Packard, San Fernando, CA, USA),
in the analytical column mobile phase were filtered and an SPS pre-column (C , 1033.0 mm, Regis18
Fig. 2. Schematic diagram of the column-switching setup. Position A: on-line sample extraction; position B: chiral separation and MS
detection. Solid line, the flow path of the extraction mobile phase (0.05 M NH Ac in 10% CH CN in water, 1.0 ml /min). Dashed line, the4 3
flow path of the LC–MS mobile phase (CH CN–CH OH–HAc–TEA, 95:5:0.5:0.3, v /v, 0.25 ml /min).3 3
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Technologies, Morton Grove, IL, USA). The LC– The valve was switched back to the position A at 15
MS (UV) system used for chiral separation and min after the injection, and the pre-column was
detection consisted of a HP 1100 binary LC gradient equilibrated by pumping the mobile phase of 0.05 M
pump, a HP 1100 variable-wavelength UV detector, NH Ac (pH 6.98) in 10% (v/v) CH CN at a flow-4 3
a Cyclobond I 2000 native b-CD phase analytical rate of 1 ml /min until the next injection.
column (25032.0 mm, Advanced Separation Tech-
nologies, Whippany, NJ, USA), an ultra-low dead ESI-MS detection
volume stainless steel in-line filter (0.5-mm pore,
0.23-ml dead volume, Upchurch Scientific, Oak The MS detector was operated in the positive
Harbor, WA, USA), and a Quattro II triple quad- electrospray ionization (ESI1) mode. It was tuned
rupole mass spectrometer with a MassLynx data by infusion of a mixture of analytes in analytical
acquisition system from Micromass (Manchester, column mobile phase (at 170 mg/ml for THP, 167
UK). mg/ml for procyclidine, 167 mg/ml for biperiden,
The connection of the analytical column to the MS and 84 mg/ml for diphenidol) with a Harvard
detector was via a Valco (Houston, TX, USA) syringe pump (Harvard Apparatus, South Natick,
stainless steel splitting tee (1 /16 in.30.25 mm; 1 MA, USA) at a flow-rate of 3 ml /min via a 75-mm
in.52.54 cm) at a post-column split ratio of 1:8. The I.D. fused-silica capillary. The ionization conditions
split ratio was adjusted by the resistance of the two were: nitrogen desolvation gas at 300 l /h, capillary
outgoing lines with the smaller flow connected to the at 3.00 kV, cone at 240 V, skimmer at 5 V, radio
MS detector and the larger one to the UV detector. frequency (RF) lens at 0.5 V, ion source temperature
For all the connections, high-pressure polyether ether at 708C, low- and high-mass resolution at 15, ion
ketone (PEEK) tubing (1 /16 in. O.D.) was used. energy at 1.6 V, and photomultiplier at 2650 V.
0.01 in. I.D. tubing was used for the on-line sample Full scan spectra were acquired in the continuum
extraction system, and 0.005 in. I.D. for the LC–MS mode over the mass range of 200–400 u at the scan
system. speed of 200 u/s. Selected-ion monitoring (SIM)
mode was used for quantitation by sequentially
On-line sample extraction and LC chiral monitoring quasi-molecular ions of each analyte (m /
1 1
separation z 288 [procyclidine1H] , m /z 302 [THP1H] , m /z
1 1310 [I.S.1H] , and m /z 312 [biperiden1H] ). Data
An SPS pre-column was used for the on-line acquisition was done with a dwell time of 0.5 s, one
sample extraction. Human serum containing DL-tri- replicate for each data point, and an inter-scan delay
hexyphenidyl hydrochloride, DL-biperiden hydrochlo- of 0.02 s. Ionization parameters used were the same
ride, DL-procyclidine hydrochloride, and diphenidol as those described above.
hydrochloride (internal standard, I.S.) or an aqueous The MS–MS detection mode (MRM) was also
mixture of the standard solutions was first filtered examined. The MRM data acquisition was based on
using a cellulose-acetate syringe filter. Then, a 50-ml mass fragmentation reactions of each parent ion (e.g.,
portion of the sample was injected by the auto- m /z 288 for procyclidine, m /z 302 for THP, m /z 310
sampler onto the SPS pre-column with a mobile for the I.S., and m /z 312 for biperiden). The ioniza-
phase of 0.05 M NH Ac (pH 6.98) in 10% (v/v) tion conditions of MRM mode were the same as4
CH CN at a flow-rate of 1 ml /min, and the switch- those used in SIM data acquisition mode (see3
ing valve in position A (Fig. 2). After 4-min sample earlier). In order to find appropriate mass fragmenta-
extraction and cleanup, the mobile phase was tion reactions, daughter spectra were acquired in
changed to CH CN–CH OH–HAc–TEA (95:5: continuum mode over the mass range of 50–350 u3 3
0.5:0.3, v /v), and the flow-rate was reduced to 0.25 with the scan speed of 300 u/s. The low- and
ml /min by switching the valve to the position B high-mass resolution was 10 for the first quadrupole
(Fig. 2). The drugs and the internal standard were and 15 for the third. The collision gas was Ar at a
23
eluted from the pre-column and separated in the pressure of 2.6?10 mbar. The resulting spectra
b-CD analytical column by the same mobile phase. were averaged over 2-min time windows. The MRM
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data acquisition was done with the dwell time of 0.5 phase should contain a buffer with pH close to the
s, inter-scan delay time of 0.02 s, and collision physiological value. Furthermore, the mobile phase
energy of 20 eV for each acquisition function. Mass should have weak elution strength in order to retain
fragmentation reactions used for MRM data acquisi- the analytes on column. When the hydrophobic
tion were m /z 288fi m /z 84 for procyclidine, m /z analytes interact with the C internal phase, they18
302fi m /z 98 for THP, m /z 310fi m /z 129 for the tend to be retained inside the packing material pores,
I.S., and m /z 312fi m /z 98 for biperiden. allowing them to separate from the protein sample
matrix.
Preparation of samples and standard serum In this work, both organic modifier and buffer
solutions concentration were optimized. Mobile phases for
column-switching techniques are commonly based
Serum standard and sample solutions were pre- on phosphate buffer due to its compatibility with the
pared by spiking the mixed aqueous analyte stan- biological matrix [17–21,26]. However, phosphate
dards to the blank human serum and subsequent buffer is incompatible with ESI-MS detection; hence,
serial dilutions with blank human serum. Final serum NH Ac buffer was used as the extraction buffer in4
solutions were spiked with I.S aqueous solution in this work. CH CN was chosen as the organic3
the ratio of 20/1 (serum/I.S. solution) to produce 50 modifier because it was also the major component of
ng/ml concentration of I.S. in serum. Each serum the mobile phase used for chiral separation on the
sample /standard contained at least 95% of serum analytical column. The CH CN content was varied3
matrix. After vortex-mixing, each serum solution from 0 to 15% by the volume, and the NH Ac4
was filtered through a cellulose acetate syringe filter concentrations of 0.05 and 0.1 M at pH 6.98 were
(sterile, 47 mm, 0.45 mm pore) and transferred to an tested. Our experiments indicated that higher content
autosampler vial. of CH CN resulted in faster exclusion of the serum3
proteins from the SPS pre-column. However, at 15%
CH CN, an increased system pressure was observed3
Results and discussion indicating a partial denaturing of serum proteins on
the pre-column. As compared with 0.1 M NH Ac in4
On-line sample cleanup 10% CH CN, 0.05 M NH Ac in 10% CH CN3 4 3
resulted in longer retention of the analytes, which is
An SPS pre-column [16,18,24] was chosen in this desirable for sample cleanup. Therefore, 0.05 M
work for on-line sample cleanup based on the NH Ac at pH 6.98 in 10% CH CN was used for as4 3
structures and polarity of the analytes. According to the mobile phase for the subsequent on-line sample
the manufacturer, the SPS pre-column contains inter- cleanup.
nal and external stationary phases. The internal phase The column-switching time is an important param-
(inside the packing material pores) is a C phase eter in any on-line sample cleanup approach. If a18
that retains the hydrophobic analytes whereas the premature switching time was used, the high organic
external phase (outside the packing material pores) is content mobile phase used for chiral separation on
a hydrophilic polyoxyethylene that excludes the the analytical column would denature remaining
serum proteins through a combination of electrostatic serum proteins in the pre-column and result in
repulsion and size exclusion. This design permits column clogging. In this work, the column-switching
permeation of small analyte molecules to the internal time was determined by the experiments shown in
stationary phase. Fig. 3. Without the analytical column, the serum
The mobile phase composition used for on-line protein matrix eluted within 1 min and the analytes
sample extraction must not denature the serum did not start to elute from the pre-column until 4.5
proteins in the sample matrix. Generally, this means min using of 0.05 M NH Ac (pH 6.98) in 10%4
that the amount of organic solvent in the mobile CH CN as the mobile phase. Based on these results,3
phase should be limited to 15% or less (depending the column-switching time for the subsequent analy-
on the solvent). The aqueous portion of the mobile sis was chosen to be 4 min after sample injection
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Fig. 3. UV chromatograms of analyte mixture (top trace) and control human serum (bottom trace). Analyte concentration, 126 mg/ml water
for each drug hydrochloride; instrumentation, the same as that shown in Fig. 2 without the b-CD column; UV detection at 258 nm.
when the analytes still be retained on the SPS pre- tested in both ‘‘back-flush’’ and ‘‘forward-flush’’
column. mode. In the ‘‘back-flush’’ mode, the direction of
The effectiveness of the analytical column mobile flow of the chiral separation mobile phase through
phase for the elution of serum analytes from the SPS the pre-column is opposite to that of on-line sample
pre-column is shown in Fig. 4. In this experiment, cleanup. This approach is suitable for analytes that
50-ml samples were injected onto the SPS pre-col- are strongly retained at the front portion of the
umn with the switching valve in the position A. At pre-column. Better peak shapes may be obtained
4.0 min, the system was switched to the position B, since analytes do not have to travel through the
and the eluate from the pre-column was collected entire pre-column after the switching. The ‘‘forward-
and analyzed by ESI-MS. Mass spectra of fractions flush’’ mode is suitable for analytes that migrate
collected during the 4-min time interval after the further inside the pre-column during the sample
column switching showed that all analytes were cleanup step. In this work, the ‘‘forward-flush’’ mode
present. Furthermore, there was no significant differ- was chosen because the column-switching time
ence between peak intensities (as indicated by the chosen was close to the initial elution of the analytes.
intensity of the highest peak) of the corresponding
analyte molecular peaks for the serum sample com- LC–ESI-MS
pared to the aqueous sample. This indicates that the
analytical column mobile phase was indeed effective Due to the structural similarity between THP and
for eluting the analytes of interest from the pre- other analytes in this work, a Cyclobond I 2000
column regardless the presence of serum protein in native b-CD column [25] was chosen for their chiral
the sample matrix (see Table 2 for the recoveries of separations. The separation conditions developed for
each individual analyte). In this work, the analytical- THP enantiomers [25] were applied for the enantio-
column mobile phase not only eluted the analytes meric separation of procyclidine and biperiden with
from the SPS pre-column, but also cleaned the pre- minor modification. In order to bring the retention
column prior to the valve switching back to the times of procyclidine and biperiden to an acceptable
position B. level (less than 30 min), the mobile phase com-
The column-switching system shown in Fig. 2 was position was changed from previously reported
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Fig. 4. Mass spectra of the elution fractions from the SPS pre-column after completion of sample extraction. Fractions collected during
4-min time interval starting at the time of switching; analyte concentrations, 170 mg/ml for THP?HCl, 167 mg/ml biberiden?HCl and
procyclidine?HCl, and 84 mg/ml for diphenidol?HCl.
CH CN–CH OH–HAc–TEA (95:1:0.5:0.3, v /v) As seen in Fig. 5, the signal-to-noise (S /N) ratios3 3
[25] to CH CN–CH OH–HAc–TEA (95:5:0.5:0.3, in this work were greater in SIM mode than that in3 3
v /v). MRM mode, which were on the contrary to many
Fig. 5 shows the mass chromatograms of LC–MS applications. Generally, even though MRM
procyclidine, biperiden, THP and diphenidol (I.S.) does not increase the analyte signals, it can eliminate
acquired in both SIM, and MRM modes. In SIM most of the chemical background and result in an
mode, the quantitation ions were m /z of 288, 312, improved S /N ratio. In SIM mode, the added selec-
302, and 310 for procyclidine, biperiden, THP and tivity of the third quadrupole is taken away; there-
diphenidol, respectively. In MRM mode, the mass fore, the S /N ratio is usually smaller in SIM mode
fragmentation reactions monitored were 288fi 84, than that of MRM mode. The explanation of our
312fi 98, 302fi 98, and 310fi 129 for procyclidine, observation come from the design of the Micromass
biperiden, THP and diphenidol, respectively. For all Quattro II ESI triple-quadrupole MS. The instrument
the parent ions, the maximal intensities of daughter has two mass detectors, the first one located at the
ions were achieved at the collision energy of 20 eV. end of the first quadrupole and the second one
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Fig. 5. LC–ESI-MS chromatograms of procyclidine, biperiden, THP, and diphenidol acquired in MRM mode (the top four traces) and in
SIM mode (the bottom four traces). Analyte enantiomer concentrations, 50 ng/ml for each drug hydrochloride in the analytical column
mobile phase.
behind the third quadrupole. Most ESI-MS–MS the second detector was used for MRM mode.
systems in use contain only one detector located Consequently, the analyte ion trajectories in SIM
behind the third quadrupole. When such a single- mode were shorter than those in MRM mode, and
detector system is used, the partial loss of ions the losses of ions due to collisions with the residual
caused by ion transmissions from first to the second gas molecules during their transmission from the first
and third qudrupoles is compensated by a dramatic to the third quadrupole were eliminated. Therefore,
decrease of chemical background in MRM mode. the S /N ratios were greater in the SIM mode in our
Therefore, improved S /N ratio is observed. How- case.
ever, in the case of two-detector system used in this The fact that the sensitivity gain due to the
work, the first detector was used for SIM mode, and decrease of background in MRM mode did not
188
outweigh the sensitivity gain caused by the shorter completely time-resolved from each other due to
ion trajectory in SIM mode suggests that the back- their structural similarity, they were readily quan-
ground noise in Fig. 5 was of electronic rather than tified by exploiting the mass selectivity of the SIM
chemical nature. In this work, SIM mode was used mode of ESI-MS detection.
for the final method validation. It is worth noting that According to Desage et al. [1], the maximal
in the case of insufficient sample cleanup, the therapeutic plasma concentration of THP after a
chemical noise can outweigh the electronic one, and single 15-mg dose was 55 ng/ml. Postmortem THP
the MRM mode may be more appropriate for concentrations after a 20-mg oral dose were found to
quantitation (so as in the case of single-detector be as high as 380 ng/ml in urine [27]. For biperiden,
MS–MS system). a 20-mg dose can produce blood concentration levels
approximately 50 ng/ml [27]. In the case of
Analytical performance procyclidine, the steady state blood concentrations of
150–630 ng/ml were reported. In overdosing and
Quantitative analysis of THP, procyclidine and drug abuse, the postmortem procyclidine concen-
biperiden was carried out using diphenidol as an trations of 4–4.4 mg/ml in blood, 11–15 mg/ml in
internal standard. Diphenidol is an achiral anti- liver, and 1.8–7 mg/ml in urine were previously
emetic drug structurally similar to the analytes (Fig. reported [27]. It should be pointed out that some of
1). Prior to the analysis, the internal standard was these concentration levels were determined after a
added to the serum samples containing analytes. The single oral dose of drug was administered. The
serum samples were then cleaned-up on-line and steady-state concentrations of these drugs would be
analyzed by LC–ESI-MS in the SIM mode. A higher.
representative chromatogram of serum sample is Table 1 shows the regression parameters of inter-
shown in Fig. 6. All drug enantiomers were stereo- nal calibrations for THP, biperiden and procyclidine
chemically resolved. Although these drugs were not enantiomers. As indicated by the correlation co-




Regression parameters of internal calibration curves for enantiomers of THP, biperiden and procyclidine (n56; confidence level595%;
calibration range: 11–600 ng/ml)
Compound Regression equation Correlation coefficient
24THP First peak y50.0167 (62.4?10 )x20.005 (60.064) 0.9996
24Second peak y50.0157 (62.4?10 )x10.006 (60.062) 0.9996
25Biperiden First peak y50.0095 (66.5?10 )x20.000 (60.017) 0.9999
24Second peak y50.0082 (61.1?10 )x20.007 (60.029) 0.9996
25Procyclidine First peak y50.0146 (69.1?10 )x10.010 (60.024) 0.9999
25Second peak y50.0126 (68.1?10 )x20.001 (60.021) 0.9999
efficients ($0.9996), the method shows excellent SPE and LC–ESI-MS system. The results shown in
linearity within the calibration ranges of 11–600 Table 2 were obtained by comparing the peak areas
ng/ml. In fact, the linearity of the method was of a serum standard with the corresponding peak
evaluated up to 1140 ng/ml and the calibration areas of an aqueous standard at the same concen-
curves still showed good correlation coefficients tration level. These results showed that the absolute
(.0.99). The detection limits of the method (defined recoveries ranged 98.4–100.4% with relative stan-
as concentration at S /N53) were determined to be 1 dard deviations (RSDs) of 2.2–8.6%. The recoveries
ng/ml. The detection limits may be further improved indicated that the compounds being studied either did
by injecting larger sample volumes onto the SPS not bind to serum proteins or their binding to serum
pre-column. Injection volumes up to 500 ml were proteins was disrupted by the SPS pre-column.
reported with some ‘‘restricted access media’’ with- Hypothetically, the binding of drug to serum proteins
out significant band broadening [18,19,21]. Accord- is governed by chemical equilibrium. When the
ing to the aforementioned studies [18,19,21], total serum sample containing drug molecule is loaded
plasma volume of 50 ml or more could be injected onto the SPS pre-column, the unbound drug parti-
onto the pre-column. If large sample volume is tions in the hydrophobic internal stationary phase
applied, more frequent replacement of the SPS pre- whereas the protein-bound drug resides in the mobile
column is needed. This is consistent with our ob- phase because of the exclusion of the large protein
servations with the SPS pre-column. Detection limits molecules from the packing material pores. New
may also be improved by use of microbore column equilibrium between the bound and unbound drug
(i.e., 1.0 mm I.D.) for chiral separation because of its molecules follows the addition of fresh eluent that
compatible flow-rate, low void volume and high carry the drug molecules to the next portion of the
separation efficiency. ‘‘naked’’ stationary phase. In accordance with their
Recovery studies of THP, biperiden, procyclidine, distribution coefficients, the unbound drug again
and internal standard were carried out by injecting resides in the hydrophobic internal stationary phase
both serum and aqueous standards into the on-line and the bound drug in the mobile phase. As the
Table 2
Absolute recoveries of diphenidol, THP, biperiden and procyclidine from human serum
% Absolute recovery
First peak RSD (%) Second peak RSD (%)
Diphenidol (I.S.) 98.4 7.3
THP 100.1 7.6 101.4 3.4
Biperiden 99.8 4.9 101.3 2.2
Procyclidine 100.4 8.5 100.4 6.7
Analyte enantiomer concentrations, 50 ng/ml each drug hydrochloride, n53.
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Table 3
Intra- and inter-assay reproducibility data (n56)
Intra-assay Inter-assay
First peak RSD (%) Second peak RSD (%) First peak RSD (%) Second peak RSD (%)
THP/I.S. 0.7960.07 6.4 0.7560.04 4.4 0.8160.08 8.8 0.7360.08 8.6
Biperiden/ I.S. 0.3860.03 8.8 0.3460.03 7.5 0.3660.03 9.7 0.3360.03 10.6
a aProcyclidine / I.S. 1.0860.05 4.5 0.9460.06 6.2 1.0360.08 8.1 0.9360.05 5.5
a
n55.
result of this ongoing process, the protein-bound It is well suited for clinical, toxicological, and
drug can be released and drug-free serum proteins pharmacological analyses where the simultaneous
can be excluded from the SPS pre-column. This analysis of the above compounds is needed. The
hypothesis was previously studied by Hermansson et method uses on-line sample extraction that replaces
al. [20,21] and their data along with the recovery the conventional time-consuming sample prepara-
data of our previous work [25] supported the theory. tions. The method can be easily automated for
The intra- and inter-assay reproducibilities of the increased sample throughput and unattended analy-
method were evaluated and the data are shown in ses.
Table 3. The intra-assay reproducibility was studied
by multiple injections of the same sample; whereas
the inter-assay reproducibility was based on the
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